BRIAN CADY: Open Payments
NPI 1083619134 · MOLINE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$975 in 66 payments from 19 companies in 2025. Trend: 2023 $1,013 · 2024 $1,248 · 2025 $975
Food & beverage: $975
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $211 |
| PFIZER INC. | 13 | $162 |
| AstraZeneca Pharmaceuticals LP | 5 | $91 |
| Otsuka America Pharmaceutical, Inc. | 3 | $79 |
| Novo Nordisk Inc | 3 | $56 |
| GlaxoSmithKline, LLC. | 2 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Phathom Pharmaceuticals, Inc. | 5 | $40 |
| Boston Scientific Corporation | 2 | $35 |
| Abbott Laboratories | 2 | $35 |
Products named: NURTEC ODT, UBRELVY, VRAYLAR, REXULTI, Ozempic, TRELEGY ELLIPTA, Kerendia, VOQUEZNA.
Industry payments across IL — which companies pay providers there.
